miércoles, 1 de julio de 2026
Virginia Expands Marijuana Access, Allowing Stores To Sell It For Recreational Use
Virginia Expands Marijuana Access, Allowing Stores To Sell It For Recreational Use
Retail license applications can be submitted starting Feb. 1, and adults 21 and older may legally purchase marijuana — up to 2 ounces — starting July 1, 2027. The state's coffers expect to see a $51 million tax boost during the first year of legal sales, according to legislative budget documents. Plus, Arkansas still plans to ban SNAP benefits from being used for sugary items.
https://kffhealthnews.org/morning-briefing/tuesday-june-30-2026/
25 States Challenge Medicaid Work Requirements
25 States Challenge Medicaid Work Requirements
A CMS rule issued this month goes beyond what the law defines as medically frail, the states argue in their lawsuit. Democratic attorneys general and governors from half the nation's states and the District of Columbia contend the strict Medicaid work rules will prevent eligible Americans from getting the healthcare they need, the AP reports.
https://kffhealthnews.org/morning-breakout/healthcare-costs-063026/
Supreme Court Ruling May Alter FTC's Ability To Be Nonpartisan Watchdog For Healthcare Industry
Supreme Court Ruling May Alter FTC's Ability To Be Nonpartisan Watchdog For Healthcare Industry
In a 6-3 vote, justices ruled that presidents can remove members of independent agencies at will. The agency at issue in the ruling, the Federal Trade Commission, is tasked with enforcing consumer protection laws in the healthcare and pharmaceutical industries, among other responsibilities. The ruling effectively ends the requirement that the FTC be bipartisan, NPR reported. Plus, rural health grant applications are now open.
https://kffhealthnews.org/morning-breakout/administration-news-063026/
Possible Marburg Disease Outbreak Detected In Uganda Near Ebola-Afflicted Area
Possible Marburg Disease Outbreak Detected In Uganda Near Ebola-Afflicted Area
The new development could make it even more difficult to contain the Ebola outbreak, Stat reported. Both diseases are viral hemorrhagic fevers. Also: Concern rises over possible disease outbreaks in the wake of the Venezuelan earthquakes.
https://kffhealthnews.org/morning-breakout/global-watch-070126/
Congressman Tom Kean Jr. Reveals He Stepped Away To Tend To Mental Health Needs
Congressman Tom Kean Jr. Reveals He Stepped Away To Tend To Mental Health Needs
The New Jersey Republican told his fellow House members that he was being treated for depression. His four-month absence did not go unnoticed and, given that he's voted against paid sick leave for his constituents, is a bitter pill for some to swallow. “He’s been able to rely on things he directly voted against,” said Yarrow Willman-Cole of the nonprofit New Jersey Citizen Action.
https://kffhealthnews.org/morning-briefing/wednesday-july-1-2026/
Anthropic Launches Claude Science To Begin Developing Drugs Using AI
Anthropic Launches Claude Science To Begin Developing Drugs Using AI
The AI giant has launched Claude Science, an application to be used in scientific laboratories, Stat reported. Anthropic will focus on creating drugs for diseases that are not being targeted by its pharma customers.
https://kffhealthnews.org/morning-breakout/pharma-and-tech-070126/
California Ends Use Of 'Sell By' Dates, Aiming To Reduce Food Waste
California Ends Use Of 'Sell By' Dates, Aiming To Reduce Food Waste
The law banning "sell by" dates begins Wednesday, leaving the “Best if Used By” and the "Use By” labels as the only two in use for product safety in California, AP reports. In news from across the nation: rural Americans' health screenings; swim lessons for kids with autism; a listeria outbreak; and more.
https://kffhealthnews.org/morning-breakout/state-watch-070126/
FDA Permits Zyn To Market Nicotine Pouches As Safer Alternative To Cigarettes
FDA Permits Zyn To Market Nicotine Pouches As Safer Alternative To Cigarettes
Twenty Zyn products will carry a modified risk claim that "using ZYN instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis." More administration news is about New York’s Medicaid Fraud Control Unit, policies regarding people with disabilities, violent policing, and more.
https://kffhealthnews.org/morning-breakout/administration-news-070126/
Supreme Court Upholds Birthright Citizenship, Allows States To Ban Trans Athletes
Supreme Court Upholds Birthright Citizenship, Allows States To Ban Trans Athletes
On Tuesday, a majority of justices reaffirmed the principle that, with few exceptions, anyone born on U.S. soil is a citizen, rejecting an executive order by President Donald Trump that would have fundamentally redefined what it means to be an American. It also upheld state laws from West Virginia and Idaho blocking the participation of transgender female athletes from girls’ and women’s sports teams.
https://kffhealthnews.org/morning-breakout/supreme-court-070126/
He Dreamed of Becoming a Physician Assistant. New Loan Rules May Thwart Him. By Lauren Sausser June 30, 2026
He Dreamed of Becoming a Physician Assistant. New Loan Rules May Thwart Him.
Benjamin Pinckney has dreamed of becoming a physician assistant since he was 20 years old but says new student loan limits enacted by Congress last year may prevent him from pursuing his goal. (Erica S. Lee for KFF Health News)
By Lauren Sausser June 30, 2026
https://kffhealthnews.org/health-industry/physician-assistant-professional-graduate-degrees-student-loan-limits/
Newsom Vowed To Transform Kids’ Mental Health. Many California Schools Are Still Waiting. By Christine Mai-Duc July 1, 2026
Newsom Vowed To Transform Kids’ Mental Health. Many California Schools Are Still Waiting.
Five years after launching an ambitious mental health program, many schools have struggled to get it up and running. Hundreds more have yet to try.
https://kffhealthnews.org/mental-health/newsom-children-mental-health-initiative-schools-left-waiting/
SBIA Presents Live Panel One for ClinicalTrials.gov: Essentials for Academic Medical Centers Live Panel One: Tuesday, July 14: 1:00 PM ET
https://collaborationcqpub1.fda.gov/content/adobeconnect/213/7/en/events/event/private/164827404/284007766/event_landing.html?connect-session=breezbreezwg5fazv34hgme9xr&sco-id=284007767&_charset_=utf-8
This virtual training is designed to help staff at academic medical centers meet the federal requirements for registering clinical studies and reporting results on ClinicalTrials.gov. Specialists from the U.S. Food and Drug Administration (FDA) and the National Institutes of Health (NIH) will address frequently asked questions regarding regulatory obligations and the ClinicalTrials.gov Protocol Registration and Results System (PRS).
This training begins with a required, pre-recorded video that you can complete at your own pace prior to registering for the live panel session that best fits your schedule or area of interest. Upon completion of the pre-recorded training, you can submit any questions you have about ClinicalTrials.gov registration and reporting via the dedicated email account ClinicalTrials.govAMCTraining@fda.hhs.gov and also through the registration process to attend a live virtual session with a panel of experts. The panel will use your questions to guide the discussion and provide relevant, practical answers. The live panel sessions are designed to build upon the information presented in the on-demand video.
To get started, please complete the required pre-recorded training at your earliest convenience. Upon completion, you may register and submit your questions for any of the three upcoming live panel sessions via the links below:
Webcast | Virtual Expanded Access to Investigational Drugs for Treatment Use - Questions and Answers April 15, 2026
The primary goal of this event was to provide attendees with a comprehensive understanding of this pathway, including the regulatory requirements and FDA’s recommendations. The session detailed the three categories of Expanded Access (EA): individual patient, intermediate-size population, and treatment INDs and protocols, and increased participants’ understanding of the criteria, submission requirements, and responsibilities of all parties involved.
Through presentation and panel discussion the webinar addressed frequently asked questions about the program, shared useful resources including forms, templates, websites, and clarified common misconceptions about the program. Attendees were able to leverage the knowledge and resources from this webinar to facilitate safe, compliant, and timely access to investigational treatments for patients in need.
https://www.fda.gov/drugs/news-events-human-drugs/expanded-access-investigational-drugs-treatment-use-questions-and-answers-04152026?utm_medium=email&utm_source=govdelivery
Suscribirse a:
Entradas (Atom)
.png)
